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ABSTRACT
Prophylactic intravenous antibiotics should be routinely administrated to patients undergoing
cardiac surgery. After cardiac surgery the patients are routinely administrated with prophylactic
intravenous antibiotics. The duration and doses of such antibiotics are still controversial and the
wide spectrum of prophylactic antibiotics used across the planet. It is important to bear in mind the
sensitivity of administrating post-surgical antibiotics, using guidelines for standard administration
prescribing are either missing or not effectively treated in many countries. However antibiotic
prophylaxis is not the only preventative measures. The most common antibiotics used in the
management of CABG associated infections different antibiotics been investigated. Different
generation of Cephalospurins are most important study groups of antibiotics. It is important to
appreciate that this reduction is not refer as a primary goal for surgical prophylaxis. To compare
the antibiotics prophylaxis utilization in Shahid Rajaei Heart Center, Tehran, Iran, with international
recognized standards, we conducted an observational 6-month study at this center, by a sectional,
descriptive and prospective study.This review including the antibiotics administrated to the patients
during their hospitalization in ICU as well as CCU in Shahid Rajaei hospital. The data gathered was
done on the bases of a questionnaire including the patients’ history and the administrated antibiotics.
. Each case is independently compared with the respective guideline in order to study its consistency
(in dose, duration and frequency) to globally-applied guideline, i.e. ASHP, ACC/AHA, NHS ESC etc.
The collected data have been analyzed by SPSS software, in order to figure out the descriptive
report. As the background characteristics, 130 patients (37 women, 93 men) with mean age of
64±8 years participated. Most of the Antibiotics prescriptions did not follow the guidelines in proper
manner. The most prevalent Antibiotics utilized is this center for reduction of SSI after CABG, are
Vancomycin, Ceftriaxone, Cefazolin and Ciprofloxacin. The most prominent problem in Antibiotics
prophylaxis utilization in the target medical center is the non-compliance of selection and duration
of antibiotics to the applicable guidelines.
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INTRODUCTION
Prophylactic intravenous antibiotics
should be routinely administrated to patients
undergoing cardiac surgery.1 In comparison to other
types of surgeries the risk of infection in cardiac
surgery is higher because of some features such
as cardiopulmonary bypass and systemic cooling
for myocardial protection, remaining some devices
after surgery (chest drains, pacing wires,
intravenous catheters), higher risk of post-operative
bleeding leading to blood transfusion, and delayed
extubation.2After cardiac surgery the patients are
routinely administrated with prophylactic
intravenous antibiotics. The duration and doses of
such antibiotics are still controversial and the wide
spectrum of prophylactic antibiotics used across
the planet. Currently the recommended antibiotics
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are beta lactams which are given 30 minutes or in
the case of glycopeptides 60 minutes prior to the
start of the surgery, However this recommendation
a sometimes hard to follow, particularly in the cases
of emergency. Incidentally the required intra-
operative doses (for prolonged surgeries) or post-
operative doses are sometimes omitted or
delayed.1
Various systemic reviews investigating
randomized clinical controlled trials been carried
out to evaluate the use of antibiotic prophylaxis in
cardiac surgeries. The most important considered
criteria were type of surgery, the timing and duration
of antibiotic prophylaxis, methods of surveillance
of surgical site infection (SSI) and mortality. One of
the important factors are the cost of antibiotics
because they are costly drugs which have specific
side effects, as well as the risk of development of
resistant micro-organisms resulted by their
extensive use.15 It is important to bear in mind the
sensitivity of administrating post-surgical
antibiotics, using guidelines for standard
administration prescribing are either missing or not
effectively treated in many countries.2,3 However
antibiotic prophylaxis is not the only preventative
measures. Other measures such as proper aseptic
surgical techniques, pre-operative screening for
potential resistant organisms, pre-operative
cleansing options and hair removal, perioperative
skin preparation, temperature and blood glucose
and maintenance of reasonable hemoglobin
saturation and post-operative wound care.2,4.
The most common antibiotics used in the
management of CABG associated infections different
antibiotics been investigated. Different generation
of Cephalospurins are most important study groups
of antibiotics. Second and third generations are
regarded to have higher advantages in comparison
to the first generations. This comparison also
indicated the superiority of this group of antibiotics
in comparison to Penicillins and or Glycopeptides
without gram negative cover. However this
advantage is not related to reduction in deep sternal
wound infection or other types of SSIs, but instead, it
is related to a noticeable reduction in post-operative
pneumonia and overall mortality. It is important to
appreciate that this reduction is not refer as a primary
goal for surgical prophylaxis. 2,3
METHODS
To compare the antibiotics prophylaxis
utilization in Shahid Rajaei Heart Center, Tehran,
Iran, with international recognized standards, we
conducted an observational 6-month study at this
center, by a sectional, descriptive and prospective
study. The choice, dose, duration and frequency of
post-operational antibiotics prophylaxis used on
patients undergoing CABG surgery at
abovementioned center. This review including the
antibiotics administrated to the patients during their
hospitalization in ICU as well as CCU in Shahid
Rajaei hospital. The trials were done on 200 patients
with during the period beginning on 30 September,
2012 up to 30 April 2013. The concentration is
mostly on utilization of antibiotics of Cephalosporin
(Ceftriaxone and Cefazolin), Vancomycin, and
ciprofloxacin as the most used ones in this medical
center. The data gathered was done on the bases
of a questionnaire including the patients’ history
and the administrated antibiotics. The main
demographic parameters recorded were age, sex,
marital status, BMI, diagnosis, type of surgery (either
CABG or a combined one), main disease and
comorbidities, drug allergies, habits, number of
hospitalization, drugs administrated in ICU and
CCU, dose and frequencies, duration, drug
interactions, cost and other laboratory parameters,
and finally post-op infection and secondary
infections. These data were collected through patient
disease history, physician’s order (patient’s record),
as well as verbal inquiry from direct physician or
nurses. Each case is independently compared with
the respective guideline in order to study its
consistency (in dose, duration and frequency) to
globally-applied guideline, i.e. ASHP, ACC/AHA,
NHS ESC etc. The collected data have been
analyzed by SPSS software, in order to figure out
the descriptive report. A flowchart diagram
describing the methodology undertaken, is shown
in Figure 1 below.
For the statistical analysis, data were
described as mean ± standard deviation (SD) or
median (Inter Quartile Renge) for interval and count
(%) for categorical variables.We was showed the
fitness of interval variables with one-sample
Kolmogorov-Smirnov testComparison between
subgroups was performed by chi-square test for
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categorical variables and Mann-Whitney U test for
numerical variablesP value < 0.05 considered as
statistically significant result. SPSS 15 for Windows
(SPSS Inc. Chicago, Illinois) was used for statistical
analysis.
RESULTS
As the background characteristics, 130
patients (37 women, 93 men) with mean age of
64±8 years participated. We also took previous
medical conditions or comorbidities into
considerations 78.5% of dose patient are already
diagnose with CAD as a top known hospitalization
background. Other Background and demographic
descriptive data are presented in table 1.
Most of the Antibiotics prescriptions did
not follow the guidelines in proper manner. However
Vancomycin prescriptions had the most compliance
with the guideline in term of correct doses being
administrated. However the duration of use for this
antibiotic did not follow the guideline. comparison
with the guideline are presented in table 2.
Significant interactions were observed
between antibiotics and Anticoagulants, ACEIs,
Antiarrhythmic drugs, Cardiac Glycosides, Insulin,
Minerals, Vitamins, Steroids, Laxatives,
Mucolytic and Anti hyperkalemia. Detailed
Interaction, between ICU medication and antibiotics
are listed in Table 3.
We observed that median cost in
Vancomycin, Cefazolin and Ciprofloxacin groups
were significantly greater than those who did use
other antibiotics. Median costs of more frequent
antibiotic prescriptions shown in table 4.
DISCUSSION
Since prior to the present study actually
no exact image and approved data were available
about Antibiotics prophylaxis in patients undergoing
CABG, this study is intended to set a cornerstone
for further investigations concerning Antibiotics
prophylaxis for CABG patients, by reviewing the
existing data and experiments in Shahid Rajaei
Heart Center, as a tertiary heart care center in
Tehran, Iran. Antimicrobial prophylaxis is used as
an essential supplementary to techniques used for
reducing the probability of SSIs after different types
of surgeries, particularly cardiovascular surgery.
Nevertheless, the consent of essentiality of
utilization of Antibiotics is not projected to the
methodology of this utilization, and the compliance
of Antibiotics Prophylaxis to internationally
recognized guidelines is perennially remaining as
a controversial issue. 7,12,13 This study is done by
assessment of Antibiotics prescribed to the patients
undergoing CABG operation in a 9-month interval
in Shahid Rajaei Heart Center.
Compliance to guidelines
After gathering and analyzing the data as
described above, we evaluated compliance of the
obtained data to either of internationally-
recognized guidelines, such as American Society
Table 1: Back ground and demographic
descriptive data (n = 180)
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Table 2: Frequency of antibiotic prescriptions followed the guideline c
Variable Compliance with the guideline (%)b
count (%)a (dose) (duration) (reception intervals)
Ceftriaxone (IV*) 74(56.9) 0 0 0
Vancomycin(IV) 99(76.2) 97(97.9) 7(0.1) 97(97.9)
Cefazolin (IV) 50(38.5) 50(100) 4(0.1) 50(100)
Ciprofloxacin (IV) 18(13.8) 17(94.4) 0 18(100)
Ampibactam (IV) 1(0.8) 0 0 0
Imipenem (IV) 2(1.5) 0 0 0
Meropenem (IV) 6(4.6) 0 0 0
Cefepim (IV) 3(2.3) 0 0 1(33.3)
Clindamycin (IV) 2(1.5) 2(100) 0 2(100)
Tazocin (IV) 3(2.3) 0 0 0
Amikacin (IV) 1(0.8) 0 0 0
Gentamycin(IV) 1(0.8) 1(100) 0 1(100)
Targocid (IV) 3(2.3) 0 0 0
Metronidazol (PO**) 1(100) 0 0 1(100)
Cotrimoxazole (IV) 1(100) 0 0 0
Colistin (IV) 1(100) 0 0 0
a = percentage computed base on all the patients.
b = percentage computed base on antibiotic prescription not all the patients. c= ASHP Guideline
** IV stands for Intravenous
** PO stands for Per Oral
of Health System Pharmacists (ASHP)8, Society for
Healthcare Epidemiology of America (SHEA)9,
National Health Service (NHS)10, American College
of Cardiology foundation /American Heart
Association (ACC/AHA)27, European Society of
Cardiology (ESC) and Centers for Disease Control
and prevention (CDC)30. SHEA advices replacing
of Cefazolin by Vancomycin and Rifampicin for
coronary artery bypass, and remains almost silent
about the dose and during of its utilization.
Therefore, this guideline shows little relevancy to
our factual studies in this article. The NHS guideline,
having strongly recommended antibiotics
prophylaxis for a duration of not more than 48 hours,
and the names and regimen of antibiotics utilization
is not described in this guideline in details. It was
observed the drug utilization in Shahid Rajaei Heart
Center shows its most compliance with ASHP
guideline.8 In the latter guideline, Cefazolin,
cefuroxime and Cefamendole are recommended
as the main agents, while Clindamycin, Vancomycin
and Azteroname are recommended as the
alternative agents in patients with β- Lactam
Allergy.8 Concerning the duration, this guideline has
recommended a antibiotics prophylaxis duration
of 24 up to 48 for post-CABG patients, except for
the ones suffering drain, catheter, MRSA or SSI
complications, for whom a utilization of more than
48 hours are recommended, according to the case
in question.
Considering the ASHP as the referent
guideline, along with other guidelines (i.e.
CDC,NHS tc), the following results have been
observed: I. Ceftriaxone, as the second mostly
common utilized Antibiotics in this center, is not
recommended in ASHP and other afore-named
guidelines.
Concerning other three prevalent
Antibiotics, i.e. Vancomycin, Cefazolin and
Ciprofloxacin, an utter compliance to the dose and
intervals recommended by the guidelines is
observed (98% to 100%).
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Table 3: Interaction between ICU medication and antibiotics
Characteristic/ Drug Interaction
Variable Yes No P
N=56 N=74 value
PPIs (n=128) 55(98.2) 73(98.6) 0.842
Analgesics (26) 10(17.9) 16(21.6) 0.595
Antiplatelets (n=126) 54(96.4) 72(97.3) 0.776
Anticoagulants (n=45) 43(76.8) 2(2.7) <0.001
Antilipid drugs(Statins) (n=120) 51(91.1) 69(93.2) 0.645
B blockers (n=122) 50(89.3) 72(97.3) 0.060
ACEIs (n=89) 32(57.1) 57(77) 0.016
CCBs (n=10) 6(10.7) 4(5.4) 0.261
Nitrates (n=11) 7(12.5) 4(5.4) 0.150
Duretics (n=45) 24(42.9) 21(28.4) 0.086
ARBs (n=29) 15(26.8) 14(18.9) 0.286
Antiarrhythmic drugs (n=7) 7(12.5) 0 0.002
Heart Glycosides (n=3) 3(5.4) 0 0.044
Insulin (n=8) 6(10.7) 2(2.7) 0.060
Antifungal drugs (n=4) 3(5.4) 1(1.4) 0.190
Antipsychotic drugs (n=4) 2(3.6) 2(2.7) 0.787
Antianxiety drugs (n=8) 5(8.9) 3(4.1) 0.252
Antidepressant drugs (n=3) 1(1.8) 2(2.7) 0.730
Minerals (n=26) 18(32.1) 8 (10.8) 0.003
Vitamins (n=27) 17(30.4) 10(13.5) 0.019
Synthetic erythropoietin (n=2) 1(1.8) 1 (1.4) 0.842
Steroids(n=4) 4(7.1) 0 0.020
Laxatives (n=6) 5(8.9) 1 (1.4) 0.041
Respiratory drugs (n=14) 7(12.5) 7(9.5) 0.580
Mucolytic (n=16) 11 (19.6) 5(6.8) 0.027
Estrogens (n=1) 1(1.8) 0 0.249
Thyroid drugs (n=1) 1(1.8) 0 0.249
Serum Amino plasma & Intra lipid (n=2) 1(1.8) 1(1.4) 0.842
Anti hyperkalemia  (n=3) 1(5.4) 0 0.044
Anti gout (n=1) 1(1.8) 0 0.249
Anti hypertensive drugs(vasodilators)  (n=2) 2(3.6) 0 0.101
Gastro entricdrugs (n=1) 1(1.8) 0 0.249
From the other side, an utter non-
compliance in duration of utilization is observed
(99.9% to 100%). These non-compliances are
mostly represented as prolonged duration of
utilization (highly longer than is recommended in
the guidelines).
Some Antibiotics recommended by
guidelines, such as Gentamycin and Clindamycin
are scarcely utilized in prescribed regimen, giving
their place to Ceftriaxone.
For further description, refer to table No. 2.
For a detailed description of Antibiotics utilization
duration distribution refer to Table No. 6, above.
The prevalence of prescribed Antibiotics
The most prevalent Antibiotics utilized is
this center for reduction of SSI after CABG, are
Vancomycin, Ceftriaxone, Cefazolin and
Ciprofloxacin. Other utilized Antibiotics are
mentioned in Table No. 2, above.
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Table 4: Relationship between costa and frequency of antibiotic prescribings
Characteristic/ Antibiotic prescription
Variable No Yes P value
Ceftriaxone (IV) 498000(198000-655500) 417600(417600-483600) 0.830
Vancomycin (IV) 198000(198000-500000) 417600(417600-556800) <0.001
Cefazolin (IV) 417600(417600-960000) 422250(198000-498000) 0.002
Ciprofloxacin (IV) 417600(417600-498000) 2038400(1099200-8126800) <0.001
a = Iranian Rials
The median cost was significantly lower in patients who did not follow the guidelines compared with those who followed
the guidelines. This could be due to the fact that guidelines are recommending more expensive antibiotics.
Table 5: Comparison of cost between patients in whom percentage
dose of antibiotics followed the guideline and in whom did not
Characteristic/ Compliance of dose with the guideline
Variable No Yes P value
Ceftriaxone (IV)  (n=74) 417600(417600-539700) - -
Vancomycin (IV)  (n=99) 198000(198000-330000) 417600(417600-600000) <0.001
Cefazolin (IV) (n=50) 417600(417600-960000) 422250(198000-498000) 0.002
Ciprofloxacin (IV) (n=18) 417600(417600-498000) 2156800(1178600-8725200) <0.001
Table 6: Duration of Antibiotics utilization after surgery
Characteristic/ Duration (hours)
Variable <48 48-92 >92
AmpCefteriaxone (n=74) 6(8.1) 62(83.8) 6(8.1)
AmpVancomycin (n=99) 9(9.1) 79(79.8) 11(11.1)
AmpCefazolin (n=50) 4(8) 39(78) 7(14)
AmpCiprofloxacin (n=18) 0 8(44.4) 10(55.6)
AmpAmpibactam (n=1) 0 0 1(100)
AmpImipenem (n=2) 1(50) 1(50) 0
AmpMeropenem (n=6) 1(16.7) 0 5(83.3)
AmpCefepim (n=3) 1(33.3) 0 2(66.7)
AmpClindamycin (n=2) 0 0 2 (100)
AmpTazocin (n=3) 0 0 3 (100)
AmpAmikacin (n=1) 0 0 1(100)
AmpGentamycin (n=1) 0 1(100) 0
AmpTargocid (n=3) 1(33.3) 0 2(66.7)
TabMetronidazol (n=1) 1(100) 0 0
AmpCotrimoxazole (n=1) 0 1(100) 0
AmpColistin (n=1) 0 0 1(100)
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* The choice of antibiotic was used on patient’s weight, comorbidities, history of allergies, and if patients was at risk of
MRSA infection.
Fig. 1: Trial flow diagram
Drug Interactions
Drugs interactions are mostly observed
among the drugs prescribed during patients’ stay
in ICU.
According to bnf standard handbook 11,
and as tabulated in Table No. 3 above,
Anticoagulants and Minerals show a significant
drug interaction P Values.
Cost Evaluation
Cost impacts of ABP is one of the factors
involved in selection of antibiotics. As instance in
the study by Stephan Harbarth et al.7 ceftriaxone is
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rolled out of the antibiotic regimen, in spite of being
potentially suitable in prolonged surgeons14,
because of its cost implications.7 As seen in Table
No. 4 above, among the most prevalent Antibiotics,
the P Value correspondent to Ceftriaxone
prescription implies no significant relationship
between cost and prescription, while for other three
antibiotics (Vancomycin, Cefazolin and
Ciprofloxacin) we can observe a significant
relationship. This relationship can be expressed in
this way that for the latter three Antibiotics, the cost
significantly increases in the case of prescription.
This observation is endorsed by Table No. 5 which
concern a comparison between these Antibiotics
based on their guideline.
Although the principles of surgical
Antibiotic prophylaxis have been outlined on
numerous occasions, misuse of antibiotics for this
purpose (especially prolonged utilization) is always
a controversial issue.16,17,18,28,29 The situation is even
worse for Iranian applications. In a pre-operation
AB prophylaxis prescription study performed in
Shariati Hospital, Tehran, Iran (S. Afhami et al.
2011), a compliance of 4.6 percent to the guidelines
was reported.19 Although it’s demonstrated that
prolonging ABP beyond 48 hours after CABG
surgery is still frequently practiced in spite of globally
recognized standard recommendations, but does
not show any significant positive effect on reducing
the risk of SSI.3,7 Moreover, it results in an increased
risk of acquired antibiotic resistance and should
therefore be avoided.7 Some researchers have
suggested that extended prophylactic use of
antibiotics is appropriate when drains or catheters
remain in situ for several days after cardiac surgery.7
though according to ASHP guideline there is no
data to support the continuation of antimicrobial
prophylaxis indwelling drains and intravascular
catheters.1,15,20-24
In a study performed by Inkster T, a shift
away from traditional Cephalosporins  is widely
observed, so that a combination of Fluxacilin and
gentamycin is reported as the most common
regimen.5 The pre-operation Antibiotics Prophylaxis
study by S. Afhami et al.19 demonstrates a result of
40.7% and 4.6% of compliance of type and duration
of the prescribed Antibiotics with guideline,
respectively; while these ratios in our study (for
Vancomycin as the most prevalently used Antibiotic)
is demonstrated as 76.2% and 0.1% respectively.
Other results from similar studies performed in
different countries around the world such as
systematic review published by Mertz et al25,
demonstrate though the type and dose of selection
of Antibiotics are usually done according to
applicable guidelines, use of prophylactic regimen
in cardiac surgery is evidently prolonged.
Investigation by suggests that post-operation
Antibiotics Prophylaxis for a duration of 24 hours
along with utilization of â-lactams, only prevents
post-operation pneumonia, but does not
significantly show prevention from DSWI and
SSIs.4,10,15,26 On the other side, the duration of more
than 48-hours does not show any significant
positive effect. A study performed in Harvard Medical
University7 supports that ABP is sufficient to be
utilized up to 48 hours after CABG surgery, and
prolonged utilization further to 48 hours not only
shows no improvement in reducing the SSI, but
also results in antimicrobial resistance.1,27
CONCLUSION
As shown above, the most prominent
problem in Antibiotics prophylaxis utilization in the
target medical center is the non-compliance of
selection and duration of antibiotics to the
applicable guidelines. This problem can be
illustrated to be mainly resulted from some reasons
such as lack of adequate trainings to the nurses in
order to keep them updated about the most recent
finding and optimum methods, lack of evaluation
forms and procedure in order to register and
evaluate he utilized Antibiotics, non-availability of
treatment protocols in medical centers, inadequacy
of team working mentality, disregarding the cost of
antibiotics regimen and hoteling, and lack of e-
archive in the target medical center.
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